← CASTLE BIOSCIENCES INC

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($6.4m) $5.3m ($10.3m) ($31.3m) ($67.1m) ($57.5m) $18.2m ($24.2m)
Net Income (Loss) Available to Common Stockholders, Basic ($10.2m) $3.0m ($10.3m) — — — — —
Depreciation, Depletion and Amortization $287k $354k $472k $3.4m $10.5m $12.3m $16.0m $40.8m
Depreciation $287k $354k $472k $1.4m $2.3m $3.3m $4.9m $5.9m
Amortization of Debt Issuance Costs and Discounts $566k $1.9m $839k $0 — — — —
Amortization of Intangible Assets $36k $4k $0 $2.0m $8.3m $9.0m $11.1m $34.8m
Deferred Income Tax Expense (Benefit) $0 $0 $0 ($8.7m) ($1.9m) ($223k) $1.4m ($6.2m)
Share-based Payment Arrangement, Noncash Expense $294k $1.2m $8.3m $21.7m $36.3m $51.2m $50.3m $45.9m
Payment, Tax Withholding, Share-based Payment Arrangement — — — $781k $1.7m $5.1m $8.8m $11.7m
Share-based Payment Arrangement, Expense $294k $1.2m $8.3m $21.7m $36.3m $51.2m $50.3m $45.9m
Goodwill, Impairment Loss — — — — $0 $0 — —
Gain (Loss) on Extinguishment of Debt $0 $5.2m ($1.4m) $0 — — — —
Income Tax Expense (Benefit) $9k $72k $84k ($8.7m) ($1.8m) $101k $3.3m ($5.4m)
Interest Expense Nonoperating — — — — — — $577k $86k
Other Nonoperating Income (Expense) ($272k) ($2.9m) $0 — — — — $144k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $8.4m $896k ($1.7m) $4.6m $6.2m $14.9m $12.6m ($6.9m)
Increase (Decrease) in Inventories $578k $355k $980k ($327k) $1.7m $4.0m $193k $2.1m
Increase (Decrease) in Accounts Payable $197k $557k $169k ($182k) $582k $5.7m ($4.4m) $3.1m
Proceeds from Stock Options Exercised $38k $1.2m $1.6m $4.2m $833k $269k $2.0m $2.2m
Asset Acquisition Contingent Consideration Liability — — $0 $18.3m $0 $0 $0 $2.5m
Debt Securities, Available-for-sale, Realized Gain (Loss) — — — — $0 $0 $0 —
Debt Securities, Realized Gain (Loss) — — — — — — — $0
Equity Securities, FV-NI, Gain (Loss) — — — — — — — $1.5m
Equity Securities, FV-NI, Realized Gain (Loss) — — — — — — — $484k
Equity Securities, FV-NI, Unrealized Gain (Loss) — — — — — — $555k $982k
Fair Value, Option, Changes in Fair Value, Gain (Loss) $0 ($2.1m) $0 — — — — —
Goodwill — — — — $10.7m $10.7m $10.7m $10.7m
Investment Income, Interest $24k $312k $373k $68k $4.0m — $12.9m $11.8m
Operating Expenses $21.3m $37.2m — — — — — —
Other Operating Income (Expense), Net — — $1.9m $0 — — — —
Net Cash Provided by (Used in) Operating Activities ($12.3m) $7.0m $9.9m ($19.0m) ($41.7m) ($5.6m) $64.9m $64.3m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $277k $937k $4.8m $3.5m $5.6m $13.6m $28.3m $36.0m
Payments to Acquire Businesses, Net of Cash Acquired — — — — $27.0m $0 $0 —
Net Cash Provided by (Used in) Investing Activities ($277k) ($937k) ($4.7m) ($66.7m) ($166.5m) ($16.2m) ($50.1m) ($60.4m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $38k $1.2m $330.0m $0 $833k $269k $2.0m $2.2m
Net Cash Provided by (Used in) Financing Activities $15.8m $88.3m $305.9m $5.4m $1.5m ($2.3m) $6.1m ($7.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3.3m $94.4m $311.0m ($80.2m) ($206.7m) ($24.1m) $20.9m ($3.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.5m $98.8m $409.9m $329.6m $122.9m $98.8m $119.7m $116.7m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.6m $2.2m $2.0m $1k $16k $11k $434k $59k
Income Taxes Paid, Net $160k ($150k) $102k $16k $120k $198k $2.5m $1.6m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.